AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17238334 — intervention group
Group type: COMPARATOR
Intervention: Care without system support of the guideline
Number of subjects: 0
Study 14698710 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnet-activated stimulation during VNS therapy
Number of subjects: 0
Study 11303323 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthyroidism (overt: SDI 0.121; latent: SDI 0.158)
Number of subjects: 171
Study 11303323 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypothyroidism (overt: SDI 0.617; latent: SDI 0.471)
Number of subjects: 171
Study 11303323 — intervention group
Group type: COMPARATOR
Intervention: Controls (healthy individuals: SDI 0.345)
Number of subjects: 171
Study 8791276 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha and high dose interleukin-2
Number of subjects: 65
Study 1365669 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg co-dergocrine mesylate (CDM)
Number of subjects: 18
Study 1365669 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 mg co-dergocrine mesylate (CDM)
Number of subjects: 18
Study 1365669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 2857949 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracentesis plus intravenous albumin infusion
Number of subjects: 72
Study 2857949 — intervention group
Group type: COMPARATOR
Intervention: Diuretics
Number of subjects: 72
Study 29198729 — intervention group
Group type: EXPERIMENTAL
Intervention: My Guide (psychoeducation & self-management program)
Number of subjects: 0
Study 29198729 — intervention group
Group type: COMPARATOR
Intervention: My Health (health education control condition)
Number of subjects: 0
Study 26577499 — intervention group
Group type: EXPERIMENTAL
Intervention: Invagination
Number of subjects: 132
Study 26577499 — intervention group
Group type: COMPARATOR
Intervention: Duct-to-mucosa anastomosis
Number of subjects: 132
Study 24945513 — intervention group
Group type: EXPERIMENTAL
Intervention: Haas appliance
Number of subjects: 48
Study 24945513 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyrax appliance
Number of subjects: 48
Study 23518431 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraarticular bovine thrombin at the time of wound closure
Number of subjects: 80
Study 23518431 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bovine thrombin)
Number of subjects: 80
Study 21425701 — intervention group
Group type: COMPARATOR
Intervention: Individuals acting alone
Number of subjects: 0
Study 21425701 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyads performing a similar task
Number of subjects: 0
Study 21425701 — intervention group
Group type: EXPERIMENTAL
Intervention: Observers perceiving dyads
Number of subjects: 0
Study 21425701 — intervention group
Group type: COMPARATOR
Intervention: Observers perceiving individuals
Number of subjects: 0
Study 21425701 — intervention group
Group type: COMPARATOR
Intervention: Observers' perception of critical action boundaries
Number of subjects: 0
Study 21425701 — intervention group
Group type: EXPERIMENTAL
Intervention: Observers perceiving critical action boundaries for dyads
Number of subjects: 0
Study 18439602 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided embryo transfer (US ET)
Number of subjects: 373
Study 18439602 — intervention group
Group type: COMPARATOR
Intervention: Clinical touch embryo transfer (Clinical touch ET)
Number of subjects: 373
Study 16416643 — intervention group
Group type: EXPERIMENTAL
Intervention: Restylane Perlane
Number of subjects: 150
Study 16416643 — intervention group
Group type: COMPARATOR
Intervention: Hylaform
Number of subjects: 150
Study 12601486 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc‐99m methoxyisobutylisonitrile (MIBI) imaging, 740 MBq dosage, imaging obtained 20 min after injection
Number of subjects: 15
Study 10509569 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple therapy and ZDV/ddl combination
Number of subjects: 1313
Study 10509569 — intervention group
Group type: COMPARATOR
Intervention: Alternating ZDV/ddl and ZDV/ddC regimens
Number of subjects: 1313
Study 10509569 — intervention group
Group type: EXPERIMENTAL
Intervention: QNPZ-4 scores
Number of subjects: 1313
Study 8984939 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 U kg‐1 r‐hu‐Epo subcutaneously, initially three doses weekly
Number of subjects: 70
Study 8984939 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 1818427 — intervention group
Group type: EXPERIMENTAL
Intervention: Nizoral cream
Number of subjects: 72
Study 1818427 — intervention group
Group type: COMPARATOR
Intervention: Clotrimazole ointment
Number of subjects: 72
Study 7039643 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 47
Study 7039643 — intervention group
Group type: COMPARATOR
Intervention: Morphine
Number of subjects: 47
Study 31918683 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncut Roux‐Y
Number of subjects: 236
Study 31918683 — intervention group
Group type: COMPARATOR
Intervention: Roux‐Y
Number of subjects: 236
Study 31159765 — intervention group
Group type: EXPERIMENTAL
Intervention: Regorafenib 160 mg/day (3 weeks followed by 1 week rest)
Number of subjects: 47
Study 29176762 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal lifestyle intervention (twice weekly group-exercises and dietary counseling)
Number of subjects: 606
Study 29176762 — intervention group
Group type: COMPARATOR
Intervention: Standard prenatal care (control)
Number of subjects: 606
Study 25677721 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized social activities intervention (ISAI)
Number of subjects: 52
Study 25677721 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (Control)
Number of subjects: 52
Study 24380759 — intervention group
Group type: EXPERIMENTAL
Intervention: Left FLE
Number of subjects: 43
Study 24380759 — intervention group
Group type: EXPERIMENTAL
Intervention: Right FLE
Number of subjects: 43
Study 24380759 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 43
Study 23051883 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraport zero stopcock with hub disinfection before injection
Number of subjects: 468
Study 23051883 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultraport zero stopcock without hub disinfection before injection
Number of subjects: 468
Study 23051883 — intervention group
Group type: COMPARATOR
Intervention: Conventional open‐lumen stopcock
Number of subjects: 468
Study 19716543 — intervention group
Group type: EXPERIMENTAL
Intervention: 17-alpha hydroxyprogesterone caproate
Number of subjects: 1094
Study 19716543 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1094
Study 18069770 — intervention group
Group type: EXPERIMENTAL
Intervention: subcutaneous rhGH (0.15 IU/kg)
Number of subjects: 48
Study 18069770 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48
Study 15262836 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 748
Study 15262836 — intervention group
Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 748
Study 11764514 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexposure group (experimental) - subjects presented with the same set of stimuli in either the right or left hemifield, with nonattended symbols in the opposite hemifield.
Number of subjects: 0
Study 11764514 — intervention group
Group type: COMPARATOR
Intervention: Control group - subjects presented with a pair of geometric figures in either the right or left visual hemifield.
Number of subjects: 0
Study 11264639 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 97
Study 11264639 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil
Number of subjects: 97
Study 11264639 — intervention group
Group type: COMPARATOR
Intervention: Dual therapy (previous study)
Number of subjects: 97
Study 9314699 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy with a focus on group cohesion
Number of subjects: 0
Study 9314699 — intervention group
Group type: EXPERIMENTAL
Intervention: Group psychotherapy with a focus on group therapeutic alliance
Number of subjects: 0
Study 8350884 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal estriol (n = 50)
Number of subjects: 93
Study 8350884 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 43)
Number of subjects: 93
Study 8350884 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal estriol
Number of subjects: 93
Study 8350884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 3785963 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 0
Study 3785963 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 0
Study 3785963 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30964416 — intervention group
Group type: EXPERIMENTAL
Intervention: H. halys (4 adults) with Fusarium (F. verticillioides inoculum)
Number of subjects: 12
Study 30964416 — intervention group
Group type: EXPERIMENTAL
Intervention: H. halys (4 adults) without Fusarium (no inoculum)
Number of subjects: 12
Study 30964416 — intervention group
Group type: COMPARATOR
Intervention: H. halys (0 adults) with Fusarium (F. verticillioides inoculum)
Number of subjects: 12
Study 30964416 — intervention group
Group type: COMPARATOR
Intervention: H. halys (0 adults) without Fusarium (no inoculum)
Number of subjects: 12
Study 30964416 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction of H. halys and Fusarium treatments
Number of subjects: 12
Study 29034751 — intervention group
Group type: EXPERIMENTAL
Intervention: Less than two hour invasive strategy (LT2)
Number of subjects: 1075
Study 29034751 — intervention group
Group type: COMPARATOR
Intervention: Greater than two hour invasive strategy (GT2)
Number of subjects: 1075
Study 27266776 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-based exercise for 6 months
Number of subjects: 300
Study 27266776 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study 24636382 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-specific model including FACT-P subscale scores and baseline variables
Number of subjects: 236
Study 24636382 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-part model including FACT-P subdomain scores and baseline variables
Number of subjects: 236
Study 24636382 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized estimating equation model including FACT-P subdomain scores and baseline variables
Number of subjects: 236
Study 22894890 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile extract (220 mg capsules standardized to 1.2% apigenin)
Number of subjects: 57
Study 22894890 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose monohydrate NF)
Number of subjects: 57
Study 20650437 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance
Number of subjects: 1004
Study 20650437 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopic guidance
Number of subjects: 1004
Study 18760137 — intervention group
Group type: EXPERIMENTAL
Intervention: Early revascularization intervention
Number of subjects: 2368
Study 18760137 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidiabetes regimens targeting insulin sensitivity
Number of subjects: 2368
Study 18760137 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidiabetes regimens targeting insulin provision
Number of subjects: 2368
Study 16137351 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapulmonary percussive ventilation (IPV)
Number of subjects: 33
Study 16137351 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (Control group)
Number of subjects: 33
Study 12766934 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg of oral dextro-amphetamine
Number of subjects: 25
Study 12766934 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 25
Study 10634023 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) injection at the hip adductors and/or gastrocnemius
Number of subjects: 38
Study 10634023 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (BTA) injection
Number of subjects: 38
Study 10634023 — intervention group
Group type: COMPARATOR
Intervention: Control group (no BTA treatment)
Number of subjects: 38
Study 8550117 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 10
Study 8550117 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 10
Study 8550117 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 10
Study 8550117 — intervention group
Group type: COMPARATOR
Intervention: Diazepam and Alcohol (combination)
Number of subjects: 10
Study 8550117 — intervention group
Group type: COMPARATOR
Intervention: Diazepam and Propranolol (combination)
Number of subjects: 10
Study 8550117 — intervention group
Group type: COMPARATOR
Intervention: Alcohol and Propranolol (combination)
Number of subjects: 10
Study 1683422 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of Escherichia coli endotoxin
Number of subjects: 9
Study 1683422 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (control group)
Number of subjects: 9
Study 30817567 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal graft (3 layers of allogeneic cornea slices)
Number of subjects: 255
Study 30817567 — intervention group
Group type: COMPARATOR
Intervention: Scleral graft (sclera as allograft)
Number of subjects: 255
Study 30817567 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (corneal and scleral)
Number of subjects: 255
Study 29084137 — intervention group
Group type: EXPERIMENTAL
Intervention: WB+KF
Number of subjects: 20
Study 29084137 — intervention group
Group type: EXPERIMENTAL
Intervention: WB+guar gum+KF
Number of subjects: 20
Study 29084137 — intervention group
Group type: COMPARATOR
Intervention: WB+KFsug
Number of subjects: 20
Study 29084137 — intervention group
Group type: EXPERIMENTAL
Intervention: WB+guar gum+KFsug
Number of subjects: 20
Study 29084137 — intervention group
Group type: EXPERIMENTAL
Intervention: KF
Number of subjects: 20
Study 29084137 — intervention group
Group type: EXPERIMENTAL
Intervention: guar
Number of subjects: 20
Study 29084137 — intervention group
Group type: EXPERIMENTAL
Intervention: KF+guar
Number of subjects: 20
Study 25220110 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained natural apophyseal glides (SNAGs) with self‐SNAGs (n = 29)
Number of subjects: 86
Study 25220110 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive joint mobilisations (PJM) with range‐of‐motion (ROM) exercises (n = 29)
Number of subjects: 86
Study 25220110 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 28)
Number of subjects: 86
Study 24671461 — intervention group
Group type: EXPERIMENTAL
Intervention: LigaSure Small Jaw® (LSJ)
Number of subjects: 126
Study 24671461 — intervention group
Group type: COMPARATOR
Intervention: Harmonic Focus® (HF)
Number of subjects: 126
Study 22906730 — intervention group
Group type: EXPERIMENTAL
Intervention: Red wine (RW) consumption
Number of subjects: 0
Study 22906730 — intervention group
Group type: COMPARATOR
Intervention: Grape extract (GE) tablets
Number of subjects: 0
Study 19863450 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycerol monolaurate (GML) in tampons
Number of subjects: 225
Study 19863450 — intervention group
Group type: COMPARATOR
Intervention: Tampons without GML
Number of subjects: 225
Study 19863450 — intervention group
Group type: COMPARATOR
Intervention: Women's own tampons
Number of subjects: 225
Study 19151458 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02 mg/kg intravenous midazolam
Number of subjects: 151
Study 19151458 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injection of 5mg diazepam + 25 mg promethazine
Number of subjects: 151
Study 19151458 — intervention group
Group type: COMPARATOR
Intervention: 2cc of intravenous normal saline solution
Number of subjects: 151
Study 15083485 — intervention group
Group type: EXPERIMENTAL
Intervention: Skewed parametric distributions (normal, gamma, log-normal, log-logistic)
Number of subjects: 0
Study 15083485 — intervention group
Group type: EXPERIMENTAL
Intervention: Models that fit badly
Number of subjects: 0
Study 15083485 — intervention group
Group type: EXPERIMENTAL
Intervention: Different parametric models that fit the data equally well
Number of subjects: 0
Study 15083485 — intervention group
Group type: EXPERIMENTAL
Intervention: Choice of statistical model
Number of subjects: 0
Study 11388472 — intervention group
Group type: EXPERIMENTAL
Intervention: MBP (40 mg per day)
Number of subjects: 33
Study 11388472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 9554821 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium acetate
Number of subjects: 6
Study 9554821 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate suspension
Number of subjects: 6
Study 9554821 — intervention group
Group type: EXPERIMENTAL
Intervention: Aluminum phosphate binders
Number of subjects: 6
Study 7985935 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized combination of plasmapheresis followed by pulse cyclophosphamide (Ctx)
Number of subjects: 14
Study 7985935 — intervention group
Group type: COMPARATOR
Intervention: Pulse cyclophosphamide (Ctx) alone
Number of subjects: 14
Study 2688530 — intervention group
Group type: EXPERIMENTAL
Intervention: Iopromide 300
Number of subjects: 31
Study 2688530 — intervention group
Group type: COMPARATOR
Intervention: Ioxaglate 320 mgI/ml
Number of subjects: 31
Study 1048183 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP/SMX) 10 mg TMP and 50 mg SMX/KG/day orally in two divided doses
Number of subjects: 65
Study 1048183 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin 100 mg/kg/day orally in four divided doses
Number of subjects: 65
Study 31973936 — intervention group
Group type: EXPERIMENTAL
Intervention: Vd + daratumumab
Number of subjects: 0
Study 31973936 — intervention group
Group type: COMPARATOR
Intervention: Vd
Number of subjects: 0
Study 31088176 — intervention group
Group type: EXPERIMENTAL
Intervention: anthocyanin-rich fruit juice
Number of subjects: 57
Study 31088176 — intervention group
Group type: COMPARATOR
Intervention: placebo beverage (rich in vitamin C)
Number of subjects: 57
Study 28481050 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifocal treatment of myopia (3-year duration)
Number of subjects: 102
Study 25835731 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Plus Family Weight Loss (M + FWL)
Number of subjects: 520
Study 25835731 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive Health Education Program (CHE)
Number of subjects: 520
Study 25835731 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week on-line tailored intervention
Number of subjects: 520
Study 25835731 — intervention group
Group type: COMPARATOR
Intervention: Control on-line program
Number of subjects: 520
Study 23072502 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental intervention (joint observation method and infant massage)
Number of subjects: 42
Study 23072502 — intervention group
Group type: COMPARATOR
Intervention: Standard support group
Number of subjects: 42
Study 23072502 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental intervention
Number of subjects: 42
Study 21497049 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral cataract surgery (1 session)
Number of subjects: 520
Study 21497049 — intervention group
Group type: COMPARATOR
Intervention: Sequential bilateral cataract surgery (2 sessions, 4 to 6 weeks apart)
Number of subjects: 520
Study 19332969 — intervention group
Group type: EXPERIMENTAL
Intervention: GanedenBC30 (Bacillus coagulans GBI‐30, 6086)
Number of subjects: 10
Study 19332969 — intervention group
Group type: COMPARATOR
Intervention: Control (baseline measurements)
Number of subjects: 10
Study 16933312 — intervention group
Group type: EXPERIMENTAL
Intervention: Thyroidectomy
Number of subjects: 100
Study 16933312 — intervention group
Group type: COMPARATOR
Intervention: Breast surgery
Number of subjects: 100
Study 15257743 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing + subgingival administration of 10% doxycycline hyclate gel
Number of subjects: 11
Study 15257743 — intervention group
Group type: COMPARATOR
Intervention: Scaling and root planing + subgingival placebo gel
Number of subjects: 11
Study 11197756 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 16
Study 11197756 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 16
Study 9059950 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic resonance velocity mapping
Number of subjects: 8
Study 9059950 — intervention group
Group type: COMPARATOR
Intervention: Echo-Doppler measurements
Number of subjects: 8
Study 7871035 — intervention group
Group type: EXPERIMENTAL
Intervention: CP-88,059-1 (2 mg to 60 mg)
Number of subjects: 7
Study 7871035 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 3526592 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 74
Study 3526592 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin plus Gentamicin
Number of subjects: 74
Study 31311524 — intervention group
Group type: EXPERIMENTAL
Intervention: Side lying during nebulisation
Number of subjects: 39
Study 27179107 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone plus omeprazole
Number of subjects: 80
Study 27179107 — intervention group
Group type: COMPARATOR
Intervention: Algycon plus omeprazole
Number of subjects: 80
Study 25304986 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 136
Study 25304986 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-intensity physical activity
Number of subjects: 136
Study 23733720 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored, multidisciplinary supportive care programme (two sessions at treatment commencement and completion, including needs assessment, active listening, self-care education)
Number of subjects: 108
Study 23733720 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract)
Number of subjects: 108
Study 21858267 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal drug (combination of primrose, gentian root, vervain, elder flowers, and sorrel: Sinupret)
Number of subjects: 0
Study 21858267 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19117801 — intervention group
Group type: EXPERIMENTAL
Intervention: TEG-based management
Number of subjects: 69